The SIAPS team visited the DTL to assess the DGDA’s readiness for the implementation of the medicine registration process change. The team assessed the process of requesting the reporting pre-approval sample test and discussed how to incorporate the functionality of internal communication on pre-approval sample test into the PharmaDex system.
To understand the current challenges to changing the DGDA’s process, SIAPS conducted a rapid assessment of the DTL’s capacity to conduct pre-approval sample testing in August 2014. The objectives of the assessment were to:
-Review the current pre-approval sample testing process and discuss how to incorporate the functionality of sampling test communication into PharmaDex
-Identify opportunities to improve the pre-approval sampling process to ensure the quality of the products before they reach the market
-Identify any weaknesses and potential disadvantages of changing the pre-approval sampling test process
-Provide initial data to support future technical assistance to build the capacity of the DTL
- Rapid Assessment of the Capacity of Drug Testing Laboratory of the DGDA of Bangladesh — View | Download